WPC
DGX icon

Wedmont Private Capital’s Quest Diagnostics DGX Stock Holding History

Wedmont Private Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$795K Buy
3,442
+322
+10% +$74.4K 0.02% 451
2026
Q2 		$647K Buy
3,120
+86
+3% +$16.9K 0.02% 478
2026
Q1 		$603K Buy
3,034
+319
+12% +$62K 0.02% 434
2025
Q4 		$484K Sell
2,715
-225
-8% -$41K 0.02% 490
2025
Q3 		$535K Buy
2,940
+337
+13% +$59.8K 0.02% 446
2025
Q2 		$452K Buy
2,603
+78
+3% +$13.5K 0.02% 456
2025
Q1 		$414K Buy
2,525
+381
+18% +$62.6K 0.02% 431
2024
Q4 		$325K Buy
2,144
+179
+9% +$27.8K 0.02% 513
2024
Q3 		$289K Buy
1,965
+114
+6% +$17K 0.02% 522
2024
Q2 		$267K Buy
+1,851
New +$253K 0.02% 533
2023
Q1 		– Sell
-1,536
Closed -$239K – 475
2022
Q4 		$239K Buy
+1,536
New +$221K 0.04% 389
2022
Q3 		– Sell
-1,880
Closed -$250K – 376
2022
Q2 		$250K Buy
+1,880
New +$256K 0.05% 277

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Wedmont Private Capital's DGX Position: Q3 2026 in Review

Wedmont Private Capital increased its Quest Diagnostics (DGX) stake by 10% in Q3 2026, buying an estimated $74.4K and bringing the position to 3,442 shares worth $795K. The position accounts for 0.02% of the portfolio, ranked #451.

Wedmont Private Capital first reported a position in DGX in Q2 2022 and has held it in 12 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Wedmont Private Capital held 3,442 shares of Quest Diagnostics worth $795K as of Q3 2026.
  • Wedmont Private Capital bought 322 Quest Diagnostics shares in Q3 2026, an estimated $74.4K.
  • Quest Diagnostics made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #451 holding.
  • Wedmont Private Capital first reported a position in Quest Diagnostics in Q2 2022 and has held it in 12 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.